JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4001
ASE Group
ASX
$122B
| $573K | ﹤0.01% |
142,959
-39,199
| -22% | -$164K |
2013 Q2
24 quarters
|
|
|
FTR
4002
DELISTED
Frontier Communications Corp.
FTR
| $571K | ﹤0.01% |
336,092
-239,304
| -42% | -$488K |
2013 Q2
24 quarters
|
|
4003
Nokia
NOK
$60.9B
| $570K | ﹤0.01% |
114,749
+11,656
| +11% | +$61.4K |
2013 Q2
24 quarters
|
|
4004
Entravision Communication
EVC
$632M
| $569K | ﹤0.01% |
192,440
-2,046,276
| -91% | -$6.21M |
2017 Q1
9 quarters
|
|
|
NPKI
4005
NPK International
NPKI
$1.02B
| $569K | ﹤0.01% |
78,605
-27,282
| -26% | -$211K |
2016 Q4
10 quarters
|
|
|
QUOT
4006
DELISTED
Quotient Technology Inc
QUOT
| $569K | ﹤0.01% |
52,959
+30,342
| +134% | +$308K |
2017 Q4
6 quarters
|
|
|
LTHM
4007
DELISTED
Livent Corporation
LTHM
| $568K | ﹤0.01% |
80,591
-62,675
| -44% | -$563K |
2018 Q4
2 quarters
|
|
|
XENT
4008
DELISTED
Intersect ENT, Inc
XENT
| $568K | ﹤0.01% |
24,930
-7,757
| -24% | -$209K |
2014 Q3
19 quarters
|
|
4009
Matthews International
MATW
$619M
| $567K | ﹤0.01% |
16,566
+1,738
| +12% | +$63.6K |
2013 Q2
24 quarters
|
|
4010
iShares Silver Trust
SLV
$29.9B
| $566K | ﹤0.01% |
39,652
-1,650
| -4% | -$23K |
2013 Q2
24 quarters
|
|
|
CBM
4011
DELISTED
Cambrex Corporation
CBM
| $565K | ﹤0.01% |
12,223
+1,927
| +19% | +$80.8K |
2014 Q4
18 quarters
|
|
4012
Orrstown Financial Services
ORRF
$811M
| $564K | ﹤0.01% |
25,613
+18,770
| +274% | +$388K |
2017 Q4
6 quarters
|
|
|
PRO
4013
DELISTED
PROS Holdings
PRO
| $564K | ﹤0.01% |
9,088
-39,265
| -81% | -$2.07M |
2017 Q3
7 quarters
|
|
|
INWK
4014
DELISTED
InnerWorkings, Inc.
INWK
| $564K | ﹤0.01% |
142,418
-206,443
| -59% | -$751K |
2016 Q4
10 quarters
|
|
4015
Eagle Bancorp
EGBN
$863M
| $562K | ﹤0.01% |
10,376
+1,498
| +17% | +$81.7K |
2017 Q4
6 quarters
|
|
4016
Weyco Group
WEYS
$488M
| $562K | ﹤0.01% |
21,812
-602
| -3% | -$17.9K |
2017 Q4
6 quarters
|
|
|
HK
4017
DELISTED
Halcon Resources Corporation
HK
| $562K | ﹤0.01% |
3,187,244
-892,195
| -22% | -$650K |
2016 Q3
11 quarters
|
|
4018
Culp Inc
CULP
$47.9M
| $561K | ﹤0.01% |
29,728
-39,036
| -57% | -$744K |
2017 Q4
6 quarters
|
|
4019
PUT
Axalta
AXTA
$7.14B
| $560K | ﹤0.01% |
+18,700
| New | +$496K |
2019 Q2
0 quarters
|
|
4020
Smith & Wesson
SWBI
$655M
| $560K | ﹤0.01% |
87,425
+53,285
| +156% | +$377K |
2015 Q4
14 quarters
|
|
4021
Aaon
AAON
$7.26B
| $559K | ﹤0.01% |
16,922
+1,884
| +13% | +$59.8K |
2017 Q3
7 quarters
|
|
4022
Solid Biosciences
SLDB
$742M
| $559K | ﹤0.01% |
7,372
-495
| -6% | -$54K |
2018 Q1
5 quarters
|
|
|
DENN
4023
DELISTED
Denny's
DENN
| $557K | ﹤0.01% |
27,213
+1,387
| +5% | +$26.7K |
2017 Q4
6 quarters
|
|
4024
iShares US Consumer Staples ETF
IYK
$1.63B
| $554K | ﹤0.01% |
13,716
-1,797
| -12% | -$72.4K |
2017 Q4
6 quarters
|
|
4025
Kratos Defense & Security Solutions
KTOS
$8.26B
| $553K | ﹤0.01% |
24,931
-11,940
| -32% | -$225K |
2017 Q3
7 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.